TrialPanorama/TrialPanorama-database huggingface dataset:
Study 19604542 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18756184 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 12675275 — Surrogate Endpoint (SUR): Blood pressure
Study 9272401 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study 21665265 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study 11985972 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7935634 — Surrogate Endpoint (SUR): Blood pressure
Study 15381675 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15381675 — Surrogate Endpoint (SUR): Blood pressure
Study 15381675 — Surrogate Endpoint (SUR): Serum potassium
Study 23786836 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22131238 — Surrogate Endpoint (SUR): Blood pressure
Study 17323586 — Surrogate Endpoint (SUR): Blood pressure
Study 1389661 — Surrogate Endpoint (SUR): Blood pressure
Study 23736314 — Predictive Biomarker (PRD): AMPH mRNA
Genes: AMPH; AMPH1
Study 17098309 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 6135365 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 15972695 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9480136 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 28814431 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17996926 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 8640969 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 11834529 — Surrogate Endpoint (SUR): Blood pressure
Study 11834529 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16773465 — Surrogate Endpoint (SUR): Plasma ammonia
Study 11181660 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 21733370 — Surrogate Endpoint (SUR): Blood pressure
Study 21733370 — Surrogate Endpoint (SUR): Serum potassium
Study 1566986 — Surrogate Endpoint (SUR): Serum potassium
Study 3905182 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 26126419 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 23535290 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31001695 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 23412700 — Pharmacodynamic Biomarker (PDY): Nasal potential difference
Study 24088130 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study 24088130 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 19371312 — Surrogate Endpoint (SUR): Blood pressure
Study 9076577 — Surrogate Endpoint (SUR): Serum calcium
Study 8222495 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15906951 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15906951 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 7910470 — Surrogate Endpoint (SUR): Blood pressure
Study 19106155 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 20395894 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20395894 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20395894 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 28553091 — Surrogate Endpoint (SUR): Bone mineral density
Study 25128802 — Predictive Biomarker (PRD): CPA1 mRNA
Genes: CPA1; CPA
Study 12109650 — Predictive Biomarker (PRD): NAT8 mRNA
Genes: NAT8; CML1; GLA; TSC501
Study 7486359 — Surrogate Endpoint (SUR): Blood pressure
Study 28401134 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 28401134 — Predictive Biomarker (PRD): DDX53 mRNA
Genes: DDX53; CAGE
Study 25869753 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study 15569129 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 15569129 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 12882461 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 12790360 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 22222005 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8819246 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 8819246 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 21488379 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 16078956 — Surrogate Endpoint (SUR): Blood pressure
Study 9918521 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 7486184 — Surrogate Endpoint (SUR): Blood pressure
Study 24334868 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9754456 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 9754456 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 9754456 — Surrogate Endpoint (SUR): Blood pressure
Study 8198262 — Surrogate Endpoint (SUR): Blood pressure
Study 25584489 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 20003306 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 12819938 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 28974833 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 28974833 — Surrogate Endpoint (SUR): Blood pressure
Study 9249617 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23929243 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23929243 — Surrogate Endpoint (SUR): Forced vital capacity
Study 15318955 — Predictive Biomarker (PRD): LTB mRNA
Genes: LTB; TNFC; TNFSF3
Study 2438500 — Surrogate Endpoint (SUR): Blood pressure
Study 28012280 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 28012280 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 28012280 — Safety Biomarker (SAF): Interleukin 1
Study 28012280 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28012280 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 20337221 — Safety Biomarker (SAF): Biliary glycoprotein 1
Genes: CEACAM1; BGP; BGP1
Study 20337221 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 20337221 — Surrogate Endpoint (SUR): Bone mineral density
Study 10672977 — Surrogate Endpoint (SUR): Blood pressure
Study 28090594 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 28090594 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 21741230 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study 1357451 — Surrogate Endpoint (SUR): Serum calcium
Study 30348142 — Surrogate Endpoint (SUR): Blood pressure
Study 21993491 — Surrogate Endpoint (SUR): Blood pressure
Study 20178625 — Surrogate Endpoint (SUR): Blood pressure
Study 29947322 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 24664108 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 18803940 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2624617 — Surrogate Endpoint (SUR): Blood pressure
Study 2624617 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 11873073 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31076365 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study 19359148 — Surrogate Endpoint (SUR): Blood pressure
Study 2670220 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 28719834 — Predictive Biomarker (PRD): GHR mRNA
Genes: GHR
Study 24835417 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 19892540 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 15976380 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 11350261 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 11350261 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 11350261 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 20473734 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 6321195 — Surrogate Endpoint (SUR): Blood pressure
Study 29458237 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25005652 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 31382986 — Predictive Biomarker (PRD): SH2D1A mRNA
Genes: SH2D1A; DSHP; SAP
Study 21875209 — Surrogate Endpoint (SUR): Blood pressure
Study 16455437 — Surrogate Endpoint (SUR): Blood pressure
Study 12958610 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 12958610 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 9177404 — Surrogate Endpoint (SUR): Bone mineral density
Study 26387144 — Predictive Biomarker (PRD): Hormone receptor
Study 11737121 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11737121 — Surrogate Endpoint (SUR): Blood pressure
Study 8249784 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 24576196 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 8141183 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8128938 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 17374708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17374708 — Predictive Biomarker (PRD): RETN mRNA
Genes: RETN; FIZZ3; HXCP1; RSTN; UNQ407/PRO1199
Study 30280751 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 27120177 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 27120177 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study 27120177 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 27120177 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study 7702024 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 7702024 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 2503294 — Surrogate Endpoint (SUR): Blood pressure
Study 21342490 — Surrogate Endpoint (SUR): Blood pressure
Study 19724276 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 19724276 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 226565 — Surrogate Endpoint (SUR): Blood pressure
Study 19296248 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 17768771 — Predictive Biomarker (PRD): NXF1 mRNA
Genes: NXF1; TAP
Study 3631465 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 11174292 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 9433426 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9433426 — Surrogate Endpoint (SUR): Blood pressure
Study 8948741 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 795443 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 9710300 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 30578392 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 30578392 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 22381428 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15356670 — Surrogate Endpoint (SUR): Blood pressure
Study 11368462 — Surrogate Endpoint (SUR): Blood pressure
Study 24535937 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study 10841179 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 2873601 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 24525155 — Surrogate Endpoint (SUR): Blood pressure
Study 8282635 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 8282635 — Surrogate Endpoint (SUR): Blood pressure
Study 9049974 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 23530755 — Surrogate Endpoint (SUR): Serum creatinine
Study 21498906 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16325470 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 16325470 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16325470 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12603413 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 29439650 — Surrogate Endpoint (SUR): Total kidney volume
Study 25227833 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 25227833 — Predictive Biomarker (PRD): Ribonucleoside-diphosphate reductase large subunit
Genes: RRM1; RR1
Study 25227833 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study 17852629 — Surrogate Endpoint (SUR): Serum testosterone
Study 8907133 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 1696310 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 1696310 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 1696310 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 1696310 — Predictive Biomarker (PRD): CD9 mRNA
Genes: CD9; MIC3; TSPAN29; GIG2
Study 1696310 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 1696310 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 17667021 — Surrogate Endpoint (SUR): Forced vital capacity
Study 15565575 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study 15565575 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 7040493 — Surrogate Endpoint (SUR): Blood pressure
Study 11847411 — Surrogate Endpoint (SUR): Blood pressure
Study 29490509 — Surrogate Endpoint (SUR): Blood pressure
Study 25575640 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18352997 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study 9452847 — Surrogate Endpoint (SUR): Blood pressure
Study 22752659 — Surrogate Endpoint (SUR): Blood pressure
Study 21555294 — Surrogate Endpoint (SUR): Blood pressure
Study 11066029 — Surrogate Endpoint (SUR): Forced vital capacity
Study 9337828 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 24014214 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 12865477 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12865477 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12865477 — Surrogate Endpoint (SUR): Blood pressure
Study 31868694 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 23846354 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 23846354 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23846354 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 10831163 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30367238 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 9602197 — Surrogate Endpoint (SUR): Blood pressure
Study 2738909 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 28410886 — Predictive Biomarker (PRD): TDO2 mRNA
Genes: TDO2; TDO
Study 26278649 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 26278649 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 23642944 — Surrogate Endpoint (SUR): Blood pressure
Study 21565322 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 21565322 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9263186 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 31539371 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27931053 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 27931053 — Predictive Biomarker (PRD): TPR mRNA
Genes: TPR
Study 27931053 — Surrogate Endpoint (SUR): Blood pressure
Study 19399262 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19399262 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17708625 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16787193 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 22692106 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 18071079 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11099367 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 6086772 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 20811292 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Angiotensinogen
Genes: AGT; SERPINA8
Study 20811292 — Predictive Biomarker (PRD): AGTR1 mRNA
Genes: AGTR1; AGTR1A; AGTR1B; AT2R1; AT2R1B
Study 3280128 — Predictive Biomarker (PRD): OMD mRNA
Genes: OMD; SLRR2C; UNQ190/PRO216
Study 30585267 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 30585267 — Predictive Biomarker (PRD): MAPK3 mRNA
Genes: MAPK3; ERK1; PRKM3
Study 30585267 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 28533148 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 16847290 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 12704354 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 7249899 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 22914255 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22914255 — Surrogate Endpoint (SUR): Blood pressure
Study 22914255 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 3613407 — Surrogate Endpoint (SUR): Blood pressure
Study 26189608 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 22918663 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18474764 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 18474764 — Surrogate Endpoint (SUR): Blood pressure
Study 8617086 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 18981007 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 10482985 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 8144848 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 19167589 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19167589 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19167589 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15320851 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8029088 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 30629160 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 29066163 — Predictive Biomarker (PRD): Anti-acetylcholine receptor antibody
Study 21520154 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 12764406 — Surrogate Endpoint (SUR): Blood pressure
Study 23510450 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 20883866 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 18602599 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 18602599 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 18602599 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 21723359 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 21723359 — Predictive Biomarker (PRD): SHMT1 mRNA
Genes: SHMT1
Study 21723359 — Safety Biomarker (SAF): MTHFR
Study 17173248 — Predictive Biomarker (PRD): CCN2 mRNA
Genes: CCN2; CTGF; HCS24; IGFBP8
Study 17173248 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 12717205 — Surrogate Endpoint (SUR): Serum creatinine
Study 12717205 — Surrogate Endpoint (SUR): Blood pressure
Study 27588932 — Surrogate Endpoint (SUR): Blood pressure
Study 26061985 — Predictive Biomarker (PRD): PLXNB1 mRNA
Genes: PLXNB1; KIAA0407; PLXN5; SEP
Study 23117015 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16426270 — Predictive Biomarker (PRD): NOTCH3 mRNA
Genes: NOTCH3
Study 15451899 — Predictive Biomarker (PRD): GAD2 mRNA
Genes: GAD2; GAD65
Study 12615747 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10850829 — Surrogate Endpoint (SUR): Bone mineral density
Study 24955739 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 15914346 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 27358159 — Safety Biomarker (SAF): Hyaluronic acid
Study 22570370 — Surrogate Endpoint (SUR): Blood pressure
Study 12487226 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 12487226 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 30825563 — Safety Biomarker (SAF): c-Jun N-terminal kinase
Study 30825563 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 30825563 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study 23572225 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 17904297 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 17904297 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 7851269 — Safety Biomarker (SAF): 51Cr-EDTA
Study 18511605 — Surrogate Endpoint (SUR): Blood pressure
Study 2888302 — Surrogate Endpoint (SUR): Blood pressure
Study 18196610 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study 31340493 — Surrogate Endpoint (SUR): Blood pressure
Study 31340493 — Surrogate Endpoint (SUR): Serum triglycerides